Daniel Levin, MD
Pain Medicine · Gurnee, ILNPI 1710325667
Payments from drug & device makers
Across 37 payments — averaging $49.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$565
- Boston Scientific$467
- Painteq LLC$157
- Edwards Lifesciences$130
- Curonix LLC$115
- Relievant Medsystems, Inc.$56
- plus $330 from 13 others
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 8 | $565 |
| Boston Scientific | 6 | $467 |
| Painteq LLC | 2 | $157 |
| Edwards Lifesciences | 3 | $130 |
| Curonix LLC | 3 | $115 |
| Relievant Medsystems, Inc. | 1 | $56 |
| SPR Therapeutics, Inc | 1 | $44 |
| Nalu Medical, Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $41 |
| AbbVie | 1 | $28 |
| Stryker | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| UCB, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
| Foundation Fusion Solutions, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$274
- Proclaim Family of SCS IPGs$192
- WAVEWRITER ALPHA$131
- PAINTEQ$130
- ETERNA$119
How this compares
$1,820 in reported general payments places this provider in the 45th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 14 | $10,739 |
| Buprenorphine | 12 | $4,809 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 158 | $3,104 |
| Pregabalin | 117 | $2,493 |
| Gabapentin | 212 | $2,279 |
| Celecoxib | 44 | $1,201 |
| Duloxetine Hcl | 98 | $968 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $733 |
| Tramadol Hcl | 109 | $466 |
| Tizanidine Hcl | 73 | $460 |
| Meloxicam | 133 | $377 |
| Methylprednisolone | 42 | $257 |
| Cyclobenzaprine Hcl | 27 | $245 |
| Lorazepam | 31 | $38 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Gurnee
- Ricardo VallejoBloomington$3.1M
- David DickersonEvanston$766K
- Albert SinghQuincy$357K
- Steven CohenChicago$292K
- Thomas DahlbergRockford$218K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Francesco VetriDecatur$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.